![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 291, Issue 1, 115-123, October 1999
Departments of Pharmacology (E.K.J., C.K.K.) and Medicine (W.A.H.,
E.K.J., C.K.K., Z.M., S.J.V.), Center for Clinical Pharmacology,
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
The purpose of this study was to determine whether the greater
inhibitory effect of angiotensin II (Ang II) on urinary cAMP excretion
in spontaneously hypertensive rats (SHRs) compared with normotensive
Wistar-Kyoto (WKY) rats is secondary to hypertension and/or renal
hemodynamic changes induced by Ang II. SHRs and WKY rats were treated
chronically from conception, 6 weeks of age, or 10 weeks of age
(n = 8-10) with the angiotensin-converting enzyme
inhibitor captopril (100 mg/kg/day). A fourth group was not treated
chronically with captopril (n = 7). At ~13 weeks
of age, all rats were anesthetized, given a bolus of captopril (30 mg/kg), and received an intrarenal infusion of a low dose of Ang II (1 ng/min). SHRs compared with WKY rats were normotensive, mildly
hypertensive, and moderately hypertensive when treated with captopril
from conception, 6 weeks of age, and 10 weeks of age, respectively,
whereas untreated SHRs were severely hypertensive. In SHRs, Ang II
decreased urinary cAMP excretion (p < .001), and this effect was independent of duration of captopril pretreatment (p = .696). In WKY rats, Ang II did not affect
urinary cAMP excretion. Low-dose Ang II caused small and similar
changes in renal blood flow and glomerular filtration rate in SHRs
versus WKY rats and did not affect urine volume in either strain. We
conclude that the greater effect of Ang II on urinary cAMP excretion in
SHRs is not due to hypertension or to the renal hemodynamic effects of
Ang II, but most likely to a greater effect of Ang II on some compartment of renal adenylyl cyclase activity in SHRs.
This article has been cited by other articles:
![]() |
D. S. Miller, R. Masereeuw, and K. J. Karnaky Jr. Regulation of MRP2-mediated transport in shark rectal salt gland tubules Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R774 - R781. [Abstract] [Full Text] [PDF] |
||||